- Home
- BLIN vs ALLR Comparison
BLIN vs ALLR Comparison
Compare BLIN & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- ALLR
- Stock Information
- Founded
- BLIN 2000
- ALLR 2004
- Country
- BLIN United States
- ALLR United States
- Employees
- BLIN N/A
- ALLR N/A
- Industry
- BLIN EDP Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- BLIN Technology
- ALLR Health Care
- Exchange
- BLIN Nasdaq
- ALLR Nasdaq
- Market Cap
- BLIN 16.5M
- ALLR 15.8M
- IPO Year
- BLIN 2007
- ALLR N/A
- Fundamental
- Price
- BLIN $1.46
- ALLR $1.05
- Analyst Decision
- BLIN Strong Buy
- ALLR
- Analyst Count
- BLIN 1
- ALLR 0
- Target Price
- BLIN $4.62
- ALLR N/A
- AVG Volume (30 Days)
- BLIN 29.0K
- ALLR 414.7K
- Earning Date
- BLIN 08-13-2025
- ALLR 08-04-2025
- Dividend Yield
- BLIN N/A
- ALLR N/A
- EPS Growth
- BLIN N/A
- ALLR N/A
- EPS
- BLIN N/A
- ALLR N/A
- Revenue
- BLIN $15,465,000.00
- ALLR N/A
- Revenue This Year
- BLIN $4.08
- ALLR N/A
- Revenue Next Year
- BLIN $12.95
- ALLR N/A
- P/E Ratio
- BLIN N/A
- ALLR N/A
- Revenue Growth
- BLIN 1.30
- ALLR N/A
- 52 Week Low
- BLIN $0.76
- ALLR $0.61
- 52 Week High
- BLIN $2.80
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- BLIN 44.00
- ALLR 58.87
- Support Level
- BLIN $1.35
- ALLR $0.95
- Resistance Level
- BLIN $1.54
- ALLR $1.09
- Average True Range (ATR)
- BLIN 0.08
- ALLR 0.07
- MACD
- BLIN 0.00
- ALLR 0.01
- Stochastic Oscillator
- BLIN 52.38
- ALLR 86.44
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.